Cargando…

Flavonoid Intake and MRI Markers of Brain Health in the Framingham Offspring Cohort

BACKGROUND: Although greater flavonoid intake is associated with a reduced risk of Alzheimer's disease (AD) and related dementias (ADRD), evidence relating dietary flavonoid intake to brain health based on MRI is lacking. OBJECTIVE: The objective of this study was to explore the association bet...

Descripción completa

Detalles Bibliográficos
Autores principales: Shishtar, Esra, Rogers, Gail T, Blumberg, Jeffrey B, Au, Rhoda, DeCarli, Charles, Jacques, Paul F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269753/
https://www.ncbi.nlm.nih.gov/pubmed/32211795
http://dx.doi.org/10.1093/jn/nxaa068
_version_ 1783541813913583616
author Shishtar, Esra
Rogers, Gail T
Blumberg, Jeffrey B
Au, Rhoda
DeCarli, Charles
Jacques, Paul F
author_facet Shishtar, Esra
Rogers, Gail T
Blumberg, Jeffrey B
Au, Rhoda
DeCarli, Charles
Jacques, Paul F
author_sort Shishtar, Esra
collection PubMed
description BACKGROUND: Although greater flavonoid intake is associated with a reduced risk of Alzheimer's disease (AD) and related dementias (ADRD), evidence relating dietary flavonoid intake to brain health based on MRI is lacking. OBJECTIVE: The objective of this study was to explore the association between dietary flavonoid intake and MRI measures of brain health, including total brain tissue volume (TBV), white matter hyperintensities volume (WMHV), and hippocampal volume (HV). METHODS: Eligible subjects included members of the Framingham Heart Study Offspring Cohort who were free of stroke at exam 7 and had at least 1 valid food frequency questionnaire from exams 5, 6, or 7 (n = 2086; mean age at exam 7, 60.6 y). Flavonoid intakes represented the cumulative mean of intakes across the 3 exams and were categorized based on quartiles categories of intake. TBV, WMHV, and HV were assessed at exam 7. Multiple linear regression models were used to examine the cross-sectional association between total and the 6 classes of flavonoids and the 3 aforementioned MRI measures. RESULTS: The mean (95% CI) of the WMHV of subjects in the highest quartile category of flavan-3-ols [0.56 (0.52, 0.61)] and flavonoid polymers [0.57 (0.52, 0.61)] intake was significantly smaller relative to that of subjects in the lowest quartile category of flavan-3-ols [0.65 (0.60, 0.71)] and flavonoid polymers [0.66 (0.60, 0.71)] after accounting for important demographic, lifestyle, and clinical factors. Inverse trend associations with WMHV were also seen for flavan-3-ols (P = 0.01) and flavonoid polymers (P = 0.01) as well as for total flavonoids (P = 0.01). TBV and HV were not associated with dietary flavonoid intake following the adjustment for potential confounders. CONCLUSIONS: Our results contribute to the literature on flavonoids and ADRD as they suggest that higher flavonoid intakes may affect ADRD risk in middle-aged and older adults by reducing WMHV, a marker strongly associated with ADRD.
format Online
Article
Text
id pubmed-7269753
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-72697532020-06-09 Flavonoid Intake and MRI Markers of Brain Health in the Framingham Offspring Cohort Shishtar, Esra Rogers, Gail T Blumberg, Jeffrey B Au, Rhoda DeCarli, Charles Jacques, Paul F J Nutr Nutritional Epidemiology BACKGROUND: Although greater flavonoid intake is associated with a reduced risk of Alzheimer's disease (AD) and related dementias (ADRD), evidence relating dietary flavonoid intake to brain health based on MRI is lacking. OBJECTIVE: The objective of this study was to explore the association between dietary flavonoid intake and MRI measures of brain health, including total brain tissue volume (TBV), white matter hyperintensities volume (WMHV), and hippocampal volume (HV). METHODS: Eligible subjects included members of the Framingham Heart Study Offspring Cohort who were free of stroke at exam 7 and had at least 1 valid food frequency questionnaire from exams 5, 6, or 7 (n = 2086; mean age at exam 7, 60.6 y). Flavonoid intakes represented the cumulative mean of intakes across the 3 exams and were categorized based on quartiles categories of intake. TBV, WMHV, and HV were assessed at exam 7. Multiple linear regression models were used to examine the cross-sectional association between total and the 6 classes of flavonoids and the 3 aforementioned MRI measures. RESULTS: The mean (95% CI) of the WMHV of subjects in the highest quartile category of flavan-3-ols [0.56 (0.52, 0.61)] and flavonoid polymers [0.57 (0.52, 0.61)] intake was significantly smaller relative to that of subjects in the lowest quartile category of flavan-3-ols [0.65 (0.60, 0.71)] and flavonoid polymers [0.66 (0.60, 0.71)] after accounting for important demographic, lifestyle, and clinical factors. Inverse trend associations with WMHV were also seen for flavan-3-ols (P = 0.01) and flavonoid polymers (P = 0.01) as well as for total flavonoids (P = 0.01). TBV and HV were not associated with dietary flavonoid intake following the adjustment for potential confounders. CONCLUSIONS: Our results contribute to the literature on flavonoids and ADRD as they suggest that higher flavonoid intakes may affect ADRD risk in middle-aged and older adults by reducing WMHV, a marker strongly associated with ADRD. Oxford University Press 2020-06 2020-03-25 /pmc/articles/PMC7269753/ /pubmed/32211795 http://dx.doi.org/10.1093/jn/nxaa068 Text en Copyright © The Author(s) 2020. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Nutritional Epidemiology
Shishtar, Esra
Rogers, Gail T
Blumberg, Jeffrey B
Au, Rhoda
DeCarli, Charles
Jacques, Paul F
Flavonoid Intake and MRI Markers of Brain Health in the Framingham Offspring Cohort
title Flavonoid Intake and MRI Markers of Brain Health in the Framingham Offspring Cohort
title_full Flavonoid Intake and MRI Markers of Brain Health in the Framingham Offspring Cohort
title_fullStr Flavonoid Intake and MRI Markers of Brain Health in the Framingham Offspring Cohort
title_full_unstemmed Flavonoid Intake and MRI Markers of Brain Health in the Framingham Offspring Cohort
title_short Flavonoid Intake and MRI Markers of Brain Health in the Framingham Offspring Cohort
title_sort flavonoid intake and mri markers of brain health in the framingham offspring cohort
topic Nutritional Epidemiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269753/
https://www.ncbi.nlm.nih.gov/pubmed/32211795
http://dx.doi.org/10.1093/jn/nxaa068
work_keys_str_mv AT shishtaresra flavonoidintakeandmrimarkersofbrainhealthintheframinghamoffspringcohort
AT rogersgailt flavonoidintakeandmrimarkersofbrainhealthintheframinghamoffspringcohort
AT blumbergjeffreyb flavonoidintakeandmrimarkersofbrainhealthintheframinghamoffspringcohort
AT aurhoda flavonoidintakeandmrimarkersofbrainhealthintheframinghamoffspringcohort
AT decarlicharles flavonoidintakeandmrimarkersofbrainhealthintheframinghamoffspringcohort
AT jacquespaulf flavonoidintakeandmrimarkersofbrainhealthintheframinghamoffspringcohort